SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-031682
Filing Date
2022-11-14
Accepted
2022-11-14 08:58:13
Documents
99
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1036785
2 ex31-1.htm EX-31.1 11304
3 ex31-2.htm EX-31.2 10940
4 ex32-1.htm EX-32.1 7548
5 ex32-2.htm EX-32.2 7442
  Complete submission text file 0001493152-22-031682.txt   5955904

Data Files

Seq Description Document Type Size
6 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bfri-20220930.xsd EX-101.SCH 60516
7 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bfri-20220930_cal.xml EX-101.CAL 74367
8 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bfri-20220930_def.xml EX-101.DEF 253152
9 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bfri-20220930_lab.xml EX-101.LAB 445273
10 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bfri-20220930_pre.xml EX-101.PRE 358413
93 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 782272
Mailing Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801
Business Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801 781-245-1325
Biofrontera Inc. (Filer) CIK: 0001858685 (see all company filings)

IRS No.: 473765675 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40943 | Film No.: 221380801
SIC: 2834 Pharmaceutical Preparations